Previous 10 | Next 10 |
AVEO Oncology (NASDAQ: AVEO) today reported financial results for the first quarter ended March 31, 2019 and provided a business update. “With a successful recent equity offering, together with the triggering of a FOTIVDA ® (tivozanib) milestone from EUSA, AVEO’s stre...
AVEO Oncology (NASDAQ:AVEO) today announced that members of the management team will participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit on Wednesday, May 8, 2019. The conference is being held May 7-8 in New York. About AVEO AVEO Pharmaceuticals, Inc....
NEW YORK, NY / ACCESSWIRE / April 25, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bron...
AVEO Oncology (NASDAQ:AVEO) today announced the triggering of a $2 million milestone payment to AVEO from EUSA Pharma. The milestone payment relates to the reimbursement approval and commercial launch in Spain of FOTIVDA ® (tivozanib) as a first line treatment of adult patients with ad...
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bron...
Nothing is so permanent as a temporary government program .” ― Milton Friedman The S&P 500 has risen some 15% so far in 2019, one of its fastest starts to a year in decades. The Dow is near all-time highs despite being weighed down by the recent troubles at Boeing ( B...
NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is a biopharmaceutical company, dev...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signi...
Gainers : Yangtze River Port and Logistics (NASDAQ: YRIV ) +48% . Recro Pharma (NASDAQ: REPH ) +28% . Shineco (NASDAQ: TYHT ) +27% . SG Blocks (NASDAQ: SGBX ) +18% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +18% . Amtech Systems (NASDAQ: ASYS ) +15% . Amyris (NASDAQ: AMRS ) +13...
Ocean Power Technologies (NASDAQ: OPTT ) -54% . More news on: Ocean Power Technologies, Inc., AVEO Pharmaceuticals, Inc., InspireMD, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
AVEO Pharmaceuticals Inc. Company Name:
AVEO Stock Symbol:
NASDAQ Market:
SEOUL, South Korea, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LG Chem, Ltd. (“LG Chem”) (KOSPI: 051910) today announced that it has completed its previously announced acquisition of AVEO Oncology (“AVEO”), a commercial stage, oncology-focused biopharmaceutical company committe...
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders ...
BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reminds all AVEO stockholders to vote before AVEO...